Which companies overlap with Belarusian Medical Academy of Post-Graduate Education's portfolio?

Top competitors by shared drug class: Neutec Ar-Ge San ve Tic A.Ş.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/belarusian-medical-academy-of-post-graduate-education.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Belarusian Medical Academy of Post-Graduate Education — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Belarusian Medical Academy of Post-Graduate Education pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
omeprazole+domperidone SR	omeprazole+domperidone SR	marketed	Proton pump inhibitor + dopamine antagonist combination	H+/K+-ATPase (omeprazole); dopamine D2/D3 receptors (domperidone)	Gastroenterology

Therapeutic area mix

Gastroenterology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Neutec Ar-Ge San ve Tic A.Ş · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Belarusian Medical Academy of Post-Graduate Education:

Cite this brief

Drug Landscape (2026). Belarusian Medical Academy of Post-Graduate Education — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/belarusian-medical-academy-of-post-graduate-education. Accessed 2026-05-17.